|
|
Lifespan’s A - Z Health Information Library |
||||||||||
Stereotactic radiosurgery - dischargeAlternate NamesGamma knife - discharge; Cyberknife - discharge;; Stereotactic radiotherapy - discharge;Fractionated stereotactic radiotherapy- discharge; Cyclotrons- discharge; Linear accelerator- discharge; Lineacs - discharge; Proton beam radiosurgery - discharge When You Were in the HospitalYou received stereotactic radiosurgery or radiotherapy, a form of radiation therapy that focuses high-powered x-rays onto a small area. Self-careYou may have a headache or feel dizzy after your treatment. If you had pins that held a frame in place, they will be removed before you go home.
If you had anchors placed, they will be taken out when you have received all of your treatments.
Most people go back to their regular activities the next day, if there are no complications such as swelling. Some people are kept in the hospital overnight for monitoring. You may develop black eyes during the week after surgery, but it’s nothing to worry about. You should be able to eat normal foods after your treatment. Ask your doctor about when to return to work. Follow-upYou will most likely need to have an MRI, CT scan or angiogram a few weeks or months after the procedure. Your doctor or nurse will schedule your follow-up visit. When to Call the DoctorCall your doctor if you have:
ReferencesDeAngelis LM. Tumors of the Central Nervous System and Intracranial Hypertension and Hypotension. In: Goldman L, Ausiello D. Goldman: Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier;2007:chap 199. Kavanagh BD, Timmerman RD. Stereotactic radiosurgery and stereotactic body radiation therapy: an overview of technical considerations and clinical applications. Hematol Oncol Clin North Am. 2006;20:87-95. Romanelli P, Anschel DJ. Radiosurgery for epilepsy. Lancet Neurol. 2006;5:613-620. Sneed PK, Kased N, Huang K, Rubenstein JL. Brain metastases and neoplastic meningitis. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKena WG, eds. Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008:chap 52. Zivin JA. Hemorrhagic Cerbrovascular Disease. In: Goldman L, Ausiello D. Goldman: Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier;2007:chap 432. Review Date: 1/22/2009
Reviewed By: Daniel B. Hoch, PhD, MD, Assistant Professor of Neurology, Harvard Medical School, Department of Neurology, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc. The information provided herein should not be used during any
medical emergency or for the diagnosis or treatment of any medical
condition. A licensed medical professional should be consulted for
diagnosis and treatment of any and all medical conditions. Call 911
for all medical emergencies. Links to other sites are provided for
information only -- they do not constitute endorsements of those
other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the
information contained herein is strictly prohibited.
|
||||||||||
|
|